首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Discovery of novel motilin antagonists: Conversion of tetrapeptide leads to orally available peptidomimetics
Authors:Naoki Taka  Hiroharu Matsuoka  Tsutomu Sato  Hitoshi Yoshino  Ikuhiro Imaoka  Haruhiko Sato  Ken-ichiro Kotake  Yoshikazu Kumagai  Kenshi Kamei  Ken-ichi Ozaki  Atsuko Higashida  Toshio Kuroki
Institution:1. Chemistry Research Dept. 1, Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co. Ltd, 1-135 Komakado Gotemba City, Shizuoka 412-8513, Japan;2. Pharmaceutical Technology Dept., Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co. Ltd, 1-135 Komakado Gotemba City, Shizuoka 412-8513, Japan;3. CMC Planning and Coordination Dept., Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co. Ltd, 1-135 Komakado Gotemba City, Shizuoka 412-8513, Japan;4. Pharmaceutical Research Dept. 1, Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co. Ltd, 1-135 Komakado Gotemba City, Shizuoka 412-8513, Japan;5. Discovery Platform Technology Dept., Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co. Ltd, 1-135 Komakado Gotemba City, Shizuoka 412-8513, Japan;6. Research Planning and Coordination Dept., Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co. Ltd, 1-135 Komakado Gotemba City, Shizuoka 412-8513, Japan
Abstract:We successfully discovered peptidomimetic motilin antagonists (17c and 17d) through the improvement of physicochemical properties of a tetrapeptide antagonist (2). Furthermore, with oral administration and based on motilin antagonistic activity, both compounds suppressed motilin-induced colonic and gastric motility in conscious dogs.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号